> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Pneumonia Drug Development Guidances
- URL: https://www.fdaweb.com/pneumonia-drug-development-guidances/
- Published: 2020-06-24T12:00:00.000Z
- Updated: 2026-09-14T16:19:29.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147082

FDA has published two guidances to address drug development programs for [community-acquired bacterial pneumonia](https://www.fda.gov/media/75149/download?ref=fdaweb.com) and [hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/hospital-acquired-bacterial-pneumonia-and-ventilator-associated-bacterial-pneumonia-developing-drugs?ref=fdaweb.com).

The documents do not discuss the general issues of statistical analysis or clinical trial design that are addressed in other guidances.

The guidances’ contents are Introduction, Background, Development Program (general considerations, specific efficacy trial considerations, and other considerations), References, and Appendix.